前几个月有研究表明那个药在高危人群中的有效率不到三层,对其它人群无效。早就滖下神坛了

来源: fuz 2024-05-24 20:19:12 [] [博客] [旧帖] [给我悄悄话] 本文已被阅读: 次 (1337 bytes)
本文内容已被 [ fuz ] 在 2024-05-24 20:25:59 编辑过。如有问题,请报告版主或论坛管理删除.

https://www.medscape.com/viewarticle/study-shows-nirmatrelvir-ritonavir-no-more-effective-than-2024a10006gb?form=fpf

Study Shows Nirmatrelvir–Ritonavir No More Effective Than Placebo for COVID-19 Symptom Relief

 

 

https://www.scientificamerican.com/article/paxlovid-covid-treatment-most-beneficial-for-unvaccinated-people-with-risk/

Paxlovid COVID Treatment Is Most Beneficial for Unvaccinated People with Risk Factors. Others May Not Need It

 

 

 

请您先登陆,再发跟帖!

发现Adblock插件

如要继续浏览
请支持本站 请务必在本站关闭/移除任何Adblock

关闭Adblock后 请点击

请参考如何关闭Adblock/Adblock plus

安装Adblock plus用户请点击浏览器图标
选择“Disable on www.wenxuecity.com”

安装Adblock用户请点击图标
选择“don't run on pages on this domain”